Oncomatryx Biopharma has been awarded €12.5 million in EIC Accelerator funding to advance groundbreaking ADCs for oncology. This funding includes €2.5 million in grants and €10 million in equity investment.
Amount Raised
€12.5 Million
Round Type
Venture
Autonomous Community Of The Basque CountryBiotechnologyHealth CareTherapeuticsDescription
Oncomatryx Biopharma, a biotechnology company specializing in Antibody-Drug Conjugates (ADCs) for oncology, received €12.5 million in EIC Accelerator funding. This funding, part of the EU's Horizon Europe program, includes €2.5 million in grants and €10 million in equity investment. A total of 40 companies were selected from 959 applications. This funding will help advance their Phase I clinical trial for difficult-to-treat cancers.
Quick answer
Oncomatryx Biopharma raised €12.5 Million in a funding round, dated July 15, 2025. Oncomatryx Biopharma is based in Autonomous Community Of The Basque Country, Spain.
- How much did Oncomatryx Biopharma raise?
- Oncomatryx Biopharma raised €12.5 Million in a funding round on July 15, 2025.
- What does Oncomatryx Biopharma do?
- Oncomatryx Biopharma is a biotechnology company pioneering next-generation Antibody-Drug Conjugates (ADCs) for oncology.
- Where is Oncomatryx Biopharma based and how big is it?
- Oncomatryx Biopharma is based in Autonomous Community Of The Basque Country, Spain.
- Who are the decision-makers at Oncomatryx Biopharma?
- Fundz holds 2 contacts at Oncomatryx Biopharma, including the Director of Manufacturing. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Oncomatryx Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Immuneering raised $25M on August 26, 2025.
- QurAlis raised $20M on August 21, 2025.
- Calidi Biotherapeutics raised $6.9M (Post-IPO Equity) on August 21, 2025.
- CILA Therapeutics raised an undisclosed amount (Grant) on August 15, 2025.
- Eyestem raised $10M (Series B) on August 11, 2025.
- Tevogen Inc. raised $1M (Funding Round) on August 7, 2025.
Who to call at Oncomatryx Biopharma, and when
A new round usually means Oncomatryx Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oncomatryx Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oncomatryx Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oncomatryx Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oncomatryx Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oncomatryx Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.